¡¡ |
ÄÁº¥¼ÇȦ¡¡ |
´ëȸÀÇ½Ç |
±³À°Àå 1 |
±³À°Àå 2 |
09:00~10:00 |
ES1: Interesting Cases discussion ±è±¤±â (µ¿±¹ÀÇ´ë) |
ES2: Video round of sleep disorders ±èÈ¿¿ (¼º±Õ°üÀÇ´ë)
|
|
|
Interesting cases 1. ½ÅÀ¯¿ë (°æÈñÀÇ´ë) |
Patients with NREM parasomnia ÀÌ¿ø±¸ (°í½ÅÀÇ´ë)
|
|
|
Interesting cases 2. ÁÖÀº¿¬ (¼º±Õ°üÀÇ´ë)
|
Patient with REM parasomnia ÀÌÇõÁÖ (¼¿ïÀÇ´ë)
|
|
|
Coffee Break |
|
|
Opening¡¡ |
|
|
|
10:20~11:20 |
PLENARY SYMPOSIUM À±Àοµ (¼¿ïÀÇ´ë)
|
|
|
|
Phenotyping OSA: moving beyond the AHI Peter Cistulli (University of Sidney)
|
11:20~12:35 |
PS1: OSA debates ½Åö (°í·ÁÀÇ´ë)
|
PS2: Update of Restless Legs syndrome
Á¶¿ë¿ø (°è¸íÀÇ´ë)
|
Oral Presentation 1¡¡ |
Technician Course: Áõ·Ê·Î ¹è¿ì´Â ¼ö¸é°Ë»ç 1À̼¿µ (°¿øÀÇ´ë)¡¡ |
PAP effect in mild to moderat OSA À±Ã¢È£ (¼¿ïÀÇ´ë) |
Recent RLS treament guideline
±èÁöÇö (°í·ÁÀÇ´ë)
|
|
REM sleep disorder and parasomnia Á¤À¯Áø (°¡Å縯ÀÇ´ë)
|
Oral appliance effects in patients with moderate to severe OSA
½Å¿øö (°æÈñÀÇ´ë)
|
Update of RLS treatment based on pathophysiology; dopaminergic, glutaminergic, adenosine
¹ÚÀ±°æ (ºÐ´çÁ¦»ýº´¿ø)
|
|
RLS and PLMS ½ÅÁ¤¿ø (Â÷ÀÇ´ë)
|
Selection of OSA patients who needed sleep surgery
±èÈ¿¿ (¼º±Õ°üÀÇ´ë) |
RLS and Neurodegeneration
±è´ë¿µ (Ãæ³²ÀÇ´ë)
|
|
Narcolepsy and hypersomnia ±èÅÂÁØ (±¹¸³Á¤½Åº´¿ø)
|
12:35~13:35 |
LS 1: Telemedicine in sleep disorder (sponsored by ResMed) ¹ÚÂù¼ø (°¡Å縯ÀÇ´ë)
|
LS 2: Improvement of PAP compliance (sponsored by VitalAire) ¹Ú±âÇü (°¡ÃµÀÇ´ë)
|
LS 3. Update of pharmacologic management for Excessive daytime sleepiness (sponsored by TEVA pharm)
È«½Âö (°¡µ¹¸¯ÀÇ´ë)
|
|
|
Telemedicine in OSA Ȳ°æÁø (°æÈñÀÇ´ë)
|
Common Barriers to Effective PAP Therapy
ÃÖÁöÈ£ (¼øõÇâÀÇ´ë) |
Mechanism of wakefulness
ÁÖº´¾ï (¸íÁöº´¿ø)
|
Telemedicine in Insomnia ÀüÈ«ÁØ (°Ç±¹ÀÇ´ë)
|
Methods to improve CPAP adherence º¯Á¤ÀÍ (°æÈñÀÇ´ë)
|
Pharmacological treatment of EDS ; focused on amodafinil
ÇѼ±Á¤ (¿ø±¤ÀÇ´ë)
|
13:35~14:55 |
PS3: Risk factors of OSA
¿°È£±â (ÀÎÁ¦ÀÇ´ë)
±è¼ºÅà (¿¬¼¼Ä¡´ë)
|
PS4: Cross-talk between Sleep and Circadian rhythm
ÁÖÀº¿¬ (¼º±Õ°üÀÇ´ë)ÀÌÇâ¿î (ÀÌÈÀÇ´ë)
|
PS5: Management in special population with sleep problems
±èÁö¾ð (´ë±¸°¡Å縯ÀÇ´ë)
|
Oral Presentation 2¡¡ |
Technician Course: Áõ·Ê·Î ¹è¿ì´Â ¼ö¸é°Ë»ç 2 ¾È¿µÈ¸ (¼¿ï´ëº´¿ø)¡¡ |
Obesity
Á¤Àΰæ (°æÈñÀÇ´ë)
|
An ancestral mechanism of sleep regulation: amino acid metabolism and adaptive sleep behaviors.
ÀÓÁ¤ÈÆ (¿ï»ê°úÇбâ¼ú¿ø)
|
Update of detecting and management strategies for the drowsiness of professional drivers
¾ç±¤ÀÍ (¼øõÇâÀÇ´ë)
|
|
Obstructive sleep apnea ±è¿ë¹Î (Ãæ³²ÀÇ´ë)
|
Craniofacial abnormality ¾ÈÁ¤¼· (¼¿ïÄ¡´ë)
|
Shift work and its impact on sleep, mood, alertness, and performance in fast-rotating shift workers
ÁÖÀº¿¬ (¼º±Õ°üÀÇ´ë)
|
Sleep disorders among Cancer patients : What to and How to Consider
Á¤¼®ÈÆ (¿ï»êÀÇ´ë)
|
|
Central sleep apnea ÀÓÁ¤¾Æ (ÇѸ²ÀÇ´ë)
|
Aging and sex ¹®ÇýÁø (¼øõÇâÀÇ´ë)
|
Model-based precision medicine for circadian rhythms sleep disorder
±èÀç°æ (Çѱ¹°úÇбâ¼ú¿ø)
|
Sleep disordes in patients with chronic pain
±èÁö¿µ (ºÎ»êÀÇ´ë) |
|
Pediatric OSA À̼±°æ (Â÷ÀÇ´ë)
|
Alcohol
±èÇöÁØ (¾ÆÁÖÀÇ´ë)
|
Is sleep-based non-pharmacologic intervention feasible for rotating shift workers
±èÁöÇö (´Ü±¹ÀÇ´ë)
|
|
|
CPAP and biPAP pressure titration ÀÌÁ¾Âù (½ÅÃÌ ¼¼ºê¶õ½ºº´¿ø)
|
|
|
|
|
Emergency in PSG study
Á¶¿µÀç (¼¿ïÀÇ´ë)
|
¡¡ |
Coffee Break |
15:10~16:30 |
PS6: Treatment choice of children Obstructive sleep apnea
¡¡
±¸¼ö±Ç (ºÎ»ê¼º¸ðº´¿ø)
ÃÖ¼öÀü (ÀÎÁ¦ÀÇ´ë) |
PS7: Clinical practices in oral appliance therapy for OSA È«½ÂºÀ (¼º±Õ°üÀÇ´ë)
ÀÓÇö´ë (¿ø±¤Ä¡´ë)
|
PS8: Current trend in Cognitive-behavioral therapy for insomnia À±Áø»ó (Àü³²ÀÇ´ë)
|
Oral Presentation 3¡¡ |
WS1: PAP hands-on, ¼ö¸é¹«È£ÈíÁõ ȯÀÚ¿¡¼ ¾ç¾ÐÄ¡·á Àû¿ë (ResMed)
¾ç±¤ÀÍ(¼øõÇâÀÇ´ë), ±è»óÇÏ(¿¬¼¼ÀÇ´ë), ±èÇöÁØ(¾ÆÁÖÀÇ´ë)
|
PAP therapy ±è½Â¼ö (¼øõÇâÀÇ´ë)
|
Oral Appliance Therapy for OSA Peter Cistulli (University of Sidney)
|
cognitive and behaivoral models of the etiology of insomnia ÁÖ°¡¿ø(ÃæºÏ´ëº´¿ø)
|
|
|
Surgical therapy in children with OSA ¹Úµµ¾ç (¾ÆÁÖÀÇ´ë)
|
Various complications of OSA oral appliance treatment and its management
Á¶Á¤È¯ (¼¿ïÄ¡´ë)
|
basic components of CBT for insomnia ¼¼ö¿¬ (¼º½Å¿©´ë)
|
|
|
Craniofacial growth modification for SDB children: Why, When, How?
±è¼öÁ¤ (°æÈñÄ¡´ë)
|
Oral appliance application in special conditions
°¼ö°æ (°æÈñÄ¡´ë)
|
Neurofeedback therapy for sleep disorder patients Ãֽ¿ø (´ö¼º¿©´ë)
|
|
|
Orthodontic management for pediatric OSA
±è¸í¸³ (Àϸ®³ëÀÌÄ¡°ú)
|
|
|
|
|
16:30~17:50 |
PS9: Pathophysiology of OSA
ÀÌÀç¼ (¼¿ïÀÇ´ë)
Á¶ÇüÁÖ (¿ï»êÀÇ´ë) |
PS10: Sleep and Aging
Çã°æ (¿¬¼¼ÀÇ´ë) |
PS 11: RBD update¡¡ Á¤±â¿µ (¼¿ïÀÇ´ë)
|
Oral Presentation 4¡¡ |
¡¡
¡¡ |
Normal upperairway anatomy À¯¸í»ó (¿ï»êÀÇ´ë)
|
Sleep and human aging ÁøÁÖÈñ (»ï¼º¼¿ïº´¿ø)
|
Epidemiology and clinical feature of Korean RBD ; Korean RBD registry
¼±¿ìÁØ»ó (¼øõÇâÀÇ´ë)
|
|
|
Neurobiology of breathing
Á¶À翵 (¼¿ïÀÇ´ë)
|
Sleep and cognitive decline : An elderly cohort study
¼½Â¿Ï (¼¿ïÀÇ´ë)
|
Biomarker of RBD and Quatification of REM without atonia
º¯Á¤ÀÍ (°æÈñÀÇ´ë)
|
|
|
Pathophysiology of OSA
Áö±âȯ (ÀÎÁ¦ÀÇ´ë)
|
Impact of sleep loss on neurodegeneration
±è¼ºÀç (µµÀºº´¿ø)
|
Clinical significance of RBD in Parkinson's disease
ÀÌÁö¿µ (¼¿ïÀÇ´ë)
|
|
|
Pathophysiology of central apnea
±èÈÄ¿ø (Á¶¼±ÀÇ´ë)
|
|
¡¡ |
|
|
¡¡ |
ÄÁº¥¼ÇȦ¡¡ |
´ëȸÀÇ½Ç |
±³À°Àå 1 |
±³À°Àå 2 |
09:00~10:00 |
ES3: Interesting cases discussion : PAP therapy
±è»óÇÏ (¿¬¼¼ÀÇ´ë) |
ES4:interesting Cases discussion : Common sleep disorder in Pediatrics
¾È¿µ¹Î (À»ÁöÀÇ´ë)
|
WS2: PSG Workshop 1 (¼ö¸é´Ù¿ø°Ë»ç Á¤µµ°ü¸®À§¿øȸ ÀÎÁ¤ÆòÁ¡ 4Á¡)
±èÁöÇö (´Ü±¹ÀÇ´ë)
¡¡ |
¡¡ |
¡¡¡¡ |
Interesting cases 1.
±èÁ¤ºó (°í·ÁÀÇ´ë)
|
Interesting Case 1 ±èÀºÈñ (Â÷ÀÇ´ë)
|
Sleep physiology
±èÅ (±¤ÁÖ°úÇбâ¼ú¿ø)
|
Interesting cases 2.
Á¤À¯»ï (¿ï»êÀÇ´ë)
|
Interesting Case 2
Á¶±Ô¼· (ºÎ»êÀÇ´ë)
|
Indication of PSG and parameters to report
ÃÖÁöÈ£ (¼øõÇâÀÇ´ë)
|
10:00~11:15¡¡ |
PS12: Sleep and industry À±Àοµ (¼¿ïÀÇ´ë)
¡¡ |
PS13: Narcolepsy. Comparison between type 1 and type 2 narcolepsy : pathophysiology and diagnosis È«½Âö (°¡Å縯ÀÇ´ë)
|
Sleep staging rule À̼¿µ (°¿øÀÇ´ë)
|
Annual Update 1: Optimal Treatment of sleep disorder ±èÇýÀ± (°¡Å縯°üµ¿ÀÇ´ë)
|
WS3: PAP hands-on workshop2: ¼ö¸é¹«È£ÈíÁõ ȯÀÚ¿¡¼ ¾ç¾ÐÄ¡·á Àû¿ë (Philips Respironics) Á¤À¯»ï(¿ï»êÀÇ´ë), ½Å¿øö(°æÈñÀÇ´ë)
|
Çѱ¹ ¼ö¸é»ê¾÷ÀÇ ÇöÀç¿Í ¹Ì·¡ ÀÓ¿µÇö (Çѱ¹¼ö¸é»ê¾÷Çùȸ)
|
Difference of clinical feature biology between type 1 and type 2 narcolepsy
¾çÅ¿ø (°æ»óÀÇ´ë)
|
Sleep staging session hands-on course
À̼¿µ (°¿øÀÇ´ë)
|
Parmacological Treatment of RLS (30ºÐ) ¼º¹ÎÀç (ÀÇÁ¤ºÎÀÇ·á¿ø)
|
|
¼ö¸é ÀÇ»çµéÀÌ ¾Ë¾Æ¾ß ÇÒ ¼ö¸éȯ°æ Á¦Ç° À̾߱â Á¶ÀºÀÚ (À̺êÀÚ¸® ¼ö¸éȯ°æ¿¬±¸¼Ò)
|
Novel polysomnograpic biomarkers to diagnosis narcolepsyD32
±èÅ¿ø (°¡Å縯ÀÇ´ë)
|
|
¡¡ |
|
¼ö¸éÀÇÇаú ÇコÄÉ¾î – ÇöȲ ¹× °³¹ß °æÇè ¾çÁ¤¾Æ (LG U plus)
|
Difference of brain imaging and neurocognitive test
±è¼º¹Î (°¡Å縯ÀÇ´ë)
|
Respiratory scoring - adult
Á¶¼®Çö (ÇѾçÀÇ´ë) |
Update on parasomnia (30ºÐ)
ÀÌ»óµ· (±¹±º¼öµµº´¿ø) |
|
Coffee Break¡¡¡¡ |
Respiratory scoring - child
°Àº°æ (µ¿±¹ÀÇ´ë)
|
¡¡¡¡ |
¡¡¡¡ |
11:25~12:40 |
PS14: Digital Sleep : Sleep and sleep apnea monitoring with advanced technology
ÀÌÈ£¿ø (°æºÏÀÇ´ë)
|
PS15: Sleep and Cognition ÀÌ»ó¾Ï (¿ï»êÀÇ´ë)
|
|
Therapeutic approaches for circadian midalignment Á¤±ÔÀÎ (°¡Å縯ÀÇ´ë)
¡¡¡¡ |
¡¡¡¡ |
Mobile and wearable monitoring of sleep and sleep disorder
°°æ¿í (Àü³²ÀÇ´ë)
|
Disturbances in Sleep and Cognition: causation or correlation?
±èÅ (±¤ÁÖ°úÇбâ¼ú¿ø)
|
Movement scoring
ÀüÁø¼± (°æºÏÀÇ´ë) |
Therapeutic approaches for disorders of Hypersomnolence °¹Ì¸® (ÀÎÁ¦ÀÇ´ë)
|
|
SDB prescreening and monitoring using sound
±èÁ¤ÈÆ (¼¿ïÀÇ´ë)
|
Neural mechanisms underlying circadian pattern of social cognition
ÃÖÇÑ°æ (´ë±¸°æºÏ°úÇбâ¼ú¿ø)
|
Scoring session hands-on course |
PAP treatment in OSA
ÀÓÈñÁø (ÇѸ²ÀÇ´ë)
|
|
Sleep State Monitoring and OSA Detection by Sleep Breathing Sound
Zhongwei Jiang (Yamaguchi University)
|
Effect of light on sleep and cognition in Alzheimer's Disease
ÀÌÁ¤Èñ (°¿øÀÇ´ë)
|
|
|
|
12:40~13:40 |
LS 4: Advanced technologies in PAP machine (sponsored by Philips Respironics)
±è¼º¿Ï (°æÈñÀÇ´ë)
|
LS 5: Melatonin Use in sleep disorder (sponsored by Kuhnil Pharm) ¾È¿µ¹Î (À»ÁöÀÇ´ë)
|
|
|
|
Basics of PAP machine °ÇöÈñ (°¡Å縯ÀÇ´ë)
|
Melatonin in insomnia treatment
Á¤¼®ÈÆ (¿ï»êÀÇ´ë)
|
Which PAP is better in OSA? CPAP or APAP
Reasons for Failure Á¶±ÔÈ£ (¿¬¼¼ÀÇ´ë)
|
Melatonin effect on other sleep disorders ÇѼöÇö (Áß¾ÓÀÇ´ë)¡¡ |
13:40~14:45 |
PS16: Managing sleep and fatigue in shift working air crew
¼¼ö¿¬ (¼º½Å¿©´ë)
|
PS17: Sleep problems in lifetime ÀÌÀϱ٠(ºê·¹ÀνŰæ°úÀÇ¿ø)
|
WS2: PSG CPAP Workshop 2 (¼ö¸é´Ù¿ø°Ë»ç Á¤µµ°ü¸®À§¿øȸ ÀÎÁ¤ÆòÁ¡ 4Á¡)
|
Annual Update 2: Optimal Treatment of sleep disorder
Áֹΰæ (¿¬¼¼ÀÇ´ë)
|
|
Çѱ¹Çü ÇǷΰü¸®±¸Ãà¹æ¾È ¿¬±¸ ¼Ò°³_¼ö¸é´Ù¿ø°Ë»çÀÇ È¿¿ë¼º Áß½ÉÀ¸·Î
ÇѺ¹¼ø (¼º±Õ°üÀÇ´ë)
|
sleep in children ¼¿øÈñ (°í·ÁÀÇ´ë)
|
Cardiac scoring and emergency situation in PSG
±è¼¼¿ø (°¡Å縯ÀÇ´ë)
|
nonPAP treatment in OSA ±èµ¿±Ô (ÇѸ²ÀÇ´ë)
|
|
¹Î°£Ç×°ø Á¶Á¾»çÀÇ ÇǷο¡ ¿µÇâÀ» ÁÖ´Â ¿äÀÎ À̽¿µ (´ëÇÑÇ×°ø) |
sleep in pregnancy ±è±ÙÅ (°è¸íÀÇ´ë)
|
PAP modality ¼Ò°³
±è»óÇÏ (¿¬¼¼ÀÇ´ë)
|
Pharmacological Treatment of insomnia
¹æ¿µ·Õ (µ¿¾ÆÀÇ´ë)
|
|
Ç×°ø»çÀÇ Á¶Á¾»ç ¼ö¸é °ü¸® ÃÖÀ±¿µ(´ëÇÑÇ×°ø)
|
sleep in elderly ÃÖÇÏ¿¬ (Áß¾Óº¸Èƺ´¿ø)
|
Positive pressure titration guideline / Titration Case ±èÇýÀ± (°¡Å縯°üµ¿ÀÇ´ë)
|
non-pharmacological treatment of insomnia
ÀÌÁöÇö (µå¸²¼ö¸éŬ¸®´Ð) |
|
¡¡ |
¡¡ |
Q&A, quiz |
|
¡¡ |